• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
EMD

EMYRIA LIMITED

0.00% ! 5.5¢
Market Cap $40.31M  !
Technology Health Information Services
Add to My Watchlist

Emyria Limited is an Australia-based early-stage drug development company. The Company is... Emyria Limited is an Australia-based early-stage drug development company. The Company is focused on delivering and developing treatments for mental health and select neurological conditions, guided by real-world data collected with patients across its wholly owned clinical service subsidiaries. Its pipeline comprises MDMA analogue drug development and commercialization of novel serotonin-releasing agents. Its Emyria Healthcare provides evidence-based treatment for patients not finding relief from conventional care, while also helping evaluate emerging new therapies like assisted therapy for post-traumatic stress disorder (PTSD) and assisted therapy for treatment-resistant depression. Its Emyria Data is a robust and ethically sourced real-world data gathered with patients and used to improve its therapy and drug development programs. Its Emyria’s Pipeline includes new psychedelic-assisted therapies and drug treatments for mental health and select neurological diseases.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
EMD
Ann: Emyria's PTSD Program Delivers Lasting Recovery 		10/02/26 23 3.3K
10/02/26 Last post  FiSaver Comments Created with Sketch.  23  Views Created with Sketch.  3.3K 
EMD
Ann: Application for quotation of securities - EMD 		08/02/26 2 513
08/02/26 Last post  lac14 Comments Created with Sketch.  2  Views Created with Sketch.  513 
EMD
Ann: Euroz Hartleys 2026 Healthcare Forum 		05/02/26 3 798
05/02/26 Last post  FiSaver Comments Created with Sketch.  3  Views Created with Sketch.  798 
EMD
Ann: Emyria's Quarterly Investor Webinar 		04/02/26 6 1.2K
04/02/26 Last post  PVPVG Comments Created with Sketch.  6  Views Created with Sketch.  1.2K 
EMD
Ann: Application for quotation of securities - EMD 		03/02/26 0 157
03/02/26 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  157 
EMD
Ann: December 2025 Quarterly Activities Report and Appendix 4C 		28/01/26 9 1.6K
28/01/26 Last post  M Sugar Comments Created with Sketch.  9  Views Created with Sketch.  1.6K 
EMD
Ann: Application for quotation of securities - EMD 		23/01/26 0 217
23/01/26 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  217 
EMD
general talk
7 8 9
21/01/26 537 202K
21/01/26 Last post  CRUSTY1981 Comments Created with Sketch.  537  Views Created with Sketch.  202K 

See All Discussions arrow Created with Sketch.

Timeline

Application for quotation of securities - EMD
06 Feb 20:17
 
Euroz Hartleys 2026 Healthcare Forum
05 Feb 09:34
 
Application for quotation of securities - EMD
03 Feb 19:16
 
Emyria's PTSD Program Delivers Lasting Recovery
02 Feb 09:24
 
Emyria's Quarterly Investor Webinar
29 Jan 15:46
 
December 2025 Quarterly Activities Report and Appendix 4C
28 Jan 09:22
 
View More arrow Created with Sketch.

Featured News

PAR Paradigm Biopharmaceuticals to boost oral treatment of osteoarthritis for animals
right-arrow Created with Sketch.
NEWS Tungsten Mining dips -5% on $53M placement
right-arrow Created with Sketch.
NEWS Resolution Minerals drills gold discovery at Golden Gate South
right-arrow Created with Sketch.
NEWS Leeuwin Metals kicks off CY26 drilling with high-grade gold at Evanston
right-arrow Created with Sketch.
NEWS Up 380% in 1Y, Prospect Resources boots Mumbezhi copper resource by 63%
right-arrow Created with Sketch.
NEWS Paradigm Biopharmaceuticals to boost oral treatment of osteoarthritis for animals
right-arrow Created with Sketch.

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
5.5¢ 		Change
0.000(0.00%) 		Mkt cap ! $40.31M
Open High Low Volume
5.5¢ 5.5¢ 5.4¢ 378.9K

Buyers (Bids)

Vol. Price($)
389564 5.3¢
 

Sellers (Offers)

Price($) Vol.
5.5¢ 18935
Last trade - 15.52pm 11/02/2026 (20 minute delay) ?
EMD (ASX) Chart

Top Stories

Silver's slump led to refocus on gold. But rare earth neodymium is back at COVID highs

The market can be a fickle beast, and that’s perhaps most exemplified by what we’re seeing in rare earth stocks at the moment, at least when it comes to the ASX. Two weeks ago, we had an everything-metals-rally making itself felt, then came the fears prompted by th...
Listen: HotCopper Wire Podcast #041 – Our first RBA rate hike since CY23 On the HotCopper Wire this week, JD and I unpack the RBA's first "hike" since CY23 and Trump's $12B stockpile, and call a "crypto winter."
TMK Energy to undertake gas-to-power study in Mongolia TMK Energy is developing the sizeable Gurvantes XXXV CSG project in Mongolia and supporting gas-to-power use.
Exultant Mining identifies high-priority PeakView anomaly targets with 'strong foundations' Exultant Mining is now looking to drill a new multi-element soil anomaly at the Peak View project in New South Wales.
The ASX Today: CBA saves the ASX; world awaits US jobs data overnight; NdPr surge slept on Good afternoon and welcome to the ASX Today for Wednesday, I’m Jon Davidson. It looked like we were in for a flattish green day, best case after Wall Street had a lacklustre session overnight, but to kick off February earnings season down under, the Australian market had a big sur...

Featured News

NEWS Paradigm Biopharmaceuticals to boost oral treatment of osteoarthritis for animals
right-arrow Created with Sketch.
NEWS Resolution Minerals drills gold discovery at Golden Gate South
right-arrow Created with Sketch.
PAR Paradigm Biopharmaceuticals to boost oral treatment of osteoarthritis for animals
right-arrow Created with Sketch.
NEWS Tungsten Mining dips -5% on $53M placement
right-arrow Created with Sketch.
NEWS Leeuwin Metals kicks off CY26 drilling with high-grade gold at Evanston
right-arrow Created with Sketch.
NEWS Up 380% in 1Y, Prospect Resources boots Mumbezhi copper resource by 63%
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.